7Baggers

Jazz Pharmaceuticals plc Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Deferred Revenue  
 Inventory  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 00.340.691.031.381.722.072.41Billion

Jazz Pharmaceuticals plc Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 
                                                                   
  assets                                                                 
  current assets:                                                                 
  cash and cash equivalents1,189,880,000 1,861,946,000 2,412,864,000 2,218,135,000 1,355,802,000 1,443,385,000 1,506,310,000 1,335,690,000 1,282,304,000 1,167,911,000 881,482,000 839,358,000 711,265,000 490,835,000 591,448,000 671,780,000 891,400,000 2,097,533,000 1,057,769,000 741,942,000 786,082,000 701,602,000 795,175,000 637,739,000 547,466,000 499,018,000 485,081,000 453,169,000 252,615,000 239,213,000 346,995,000 366,567,000 867,966,000 979,780,000 998,859,000 921,643,000 782,603,000 575,040,000 268,255,000 245,874,000 588,462,000 504,307,000 450,511,000 189,793,000 154,543,000 170,654,000 82,076,000 101,215,000 102,396,000 65,061,000 44,794,000 22,853,000 9,574,000 18,998,000 15,595,000 12,230,000 15,772,000 17,015,000 24,903,000 49,907,000 51,202,000 100,771,000 102,945,000 119,972,000 148,000,000 
  investments480,000,000 710,000,000 580,000,000 400,000,000 625,000,000 375,000,000 120,000,000 250,000,000 80,000,000   60,000,000 60,000,000     335,000,000 1,075,000,000 1,175,000,000 910,000,000 280,000,000 275,000,000 245,000,000 285,000,000 565,000,000 330,000,000 255,000,000 200,000,000 80,000,000 60,000,000 59,418,000 48,409,000 764,000      5,502,000                          
  accounts receivable714,004,000 652,992,000 716,765,000 723,639,000 698,037,000 707,095,000 705,794,000 627,841,000 610,389,000 623,938,000 651,493,000 601,179,000 594,034,000 572,392,000 563,360,000 499,023,000 506,660,000 413,976,000 396,490,000 361,664,000 351,920,000 317,301,000 267,031,000 311,249,000 320,485,000 279,437,000 278,441,000 281,424,000 258,616,000 238,752,000 243,035,000 238,072,000 231,837,000 223,802,000 195,816,000 193,647,000 189,682,000 187,604,000 160,775,000 154,986,000 113,271,000 114,075,000 93,833,000 88,304,000 78,130,000 56,143,000 34,374,000 31,428,000 24,999,000 21,383,000 22,081,000 14,114,000 14,095,000 11,955,000 12,313,000 9,202,000 9,197,000 7,012,000 6,643,000 6,686,000 5,221,000 5,310,000 5,389,000 6,566,000 6,462,000 
  inventories504,989,000 492,776,000 480,445,000 539,302,000 542,555,000 577,321,000 597,039,000 611,827,000 657,214,000 674,778,000 714,061,000 728,074,000 861,705,000 985,454,000 1,072,721,000 1,137,851,000 1,251,259,000 115,475,000 95,396,000 91,404,000 92,534,000 85,610,000 71,108,000 68,999,000 60,707,000 43,435,000 46,156,000 46,384,000 41,344,000 39,658,000 37,653,000 32,351,000 33,291,000 25,369,000 30,018,000 30,781,000 30,692,000 37,612,000 33,098,000 36,988,000 24,868,000 28,130,000 22,830,000 30,300,000 48,355,000 16,992,000 3,909,000 4,297,000 4,736,000 5,017,000 5,046,000 4,476,000 4,429,000 3,522,000 3,426,000 4,532,000 4,193,000 4,430,000 4,788,000 6,264,000 6,219,000 2,200,000 2,213,000 3,231,000 3,216,000 
  prepaid expenses164,000,000 150,280,000 177,411,000 155,132,000 134,421,000 122,562,000 185,476,000 109,990,000 107,490,000 72,779,000 91,912,000 92,877,000 108,304,000 117,399,000 131,413,000 94,474,000 104,455,000 57,185,000 62,422,000 58,305,000 49,109,000 38,824,000 30,841,000 31,712,000 28,974,000 23,189,000 33,586,000 27,476,000 29,249,000 28,433,000 38,118,000 23,304,000 23,143,000 18,472,000 21,275,000 26,250,000 27,614,000 24,206,000 28,447,000 14,335,000 19,350,000 21,410,000 11,286,000 7,127,000 5,906,000 5,714,000 1,690,000 2,535,000 3,575,000 2,577,000 1,858,000 1,992,000 2,287,000 2,324,000 1,653,000 1,969,000 2,426,000 2,206,000 2,366,000 3,114,000 3,680,000 3,210,000 3,224,000 2,392,000 2,655,000 
  other current assets297,560,000 259,823,000 261,543,000 354,215,000 325,851,000 314,535,000 320,809,000 310,404,000 272,458,000 245,244,000 267,192,000 250,016,000 255,525,000 243,888,000 252,392,000 225,098,000 200,190,000 147,727,000 152,491,000 127,258,000 112,701,000 94,300,000 81,401,000 75,367,000 62,985,000 54,310,000 55,634,000 62,868,000 49,120,000 36,448,000 27,052,000 24,517,000 26,244,000 22,431,000 18,969,000 21,985,000 21,522,000 18,362,000 18,468,000 23,747,000 18,551,000 19,716,000 21,395,000 9,942,000 13,508,000 4,073,000 1,260,000 532,000 382,000 402,000 279,000 962,000 788,000 992,000 979,000 261,000 62,000 2,106,000 2,382,000 736,000 376,000 1,346,000 381,000 1,574,000 547,000 
  total current assets3,350,433,000 4,127,817,000 4,629,028,000 4,390,423,000 3,681,666,000 3,539,898,000 3,435,428,000 3,245,752,000 3,009,855,000 2,784,650,000 2,606,140,000 2,571,504,000 2,590,833,000 2,500,856,000 2,611,334,000 2,628,226,000 2,953,964,000 3,166,896,000 2,839,568,000 2,555,573,000 2,302,346,000 1,517,637,000 1,520,556,000 1,370,066,000 1,305,617,000 1,464,389,000 1,306,931,000 1,126,321,000 830,944,000 662,504,000 752,853,000 744,229,000 1,230,890,000 1,270,618,000 1,314,943,000 1,244,910,000 1,102,935,000 878,520,000 544,912,000 517,320,000 810,067,000 734,176,000 647,372,000 385,012,000 300,442,000 327,140,000 199,131,000 152,140,000 136,088,000 94,840,000 74,458,000 44,797,000 32,083,000 38,742,000 36,954,000 29,144,000 32,725,000 33,544,000 43,999,000 69,704,000 70,196,000 119,245,000 116,091,000 144,978,000 161,155,000 
  property, plant and equipment184,975,000 178,869,000 173,413,000 176,422,000 169,281,000 166,236,000 169,646,000 222,476,000 229,264,000 227,552,000 228,050,000 216,339,000 239,523,000 257,632,000 256,837,000 255,006,000 277,066,000 123,863,000 127,935,000 128,204,000 128,259,000 129,562,000 129,472,000 127,183,000 113,006,000 198,053,000 188,086,000 178,920,000                                      
  operating lease assets63,082,000 49,181,000 53,582,000 77,164,000 73,145,000 61,637,000 65,340,000 65,038,000 69,040,000 75,538,000 73,326,000 73,728,000 78,365,000 83,412,000 86,586,000 89,628,000 149,254,000 125,738,000 129,169,000 130,717,000 133,179,000 135,976,000 141,878,000 144,746,000 147,365,000                                         
  intangible assets4,768,987,000 4,718,158,000 4,755,695,000 5,144,217,000 5,079,462,000 5,235,496,000 5,418,039,000 5,417,860,000 5,705,777,000 5,764,209,000 5,794,437,000 5,570,394,000 6,237,959,000 6,783,057,000 7,152,328,000 7,282,579,000 7,588,029,000 2,108,046,000 2,195,051,000 2,241,107,000 2,286,126,000 2,238,658,000 2,593,030,000 2,687,941,000 2,679,393,000 2,787,281,000 2,842,277,000 2,953,146,000 3,019,035,000 3,033,103,000 2,998,780,000 3,110,439,000 1,300,761,000 1,348,160,000 1,270,777,000 1,282,955,000 1,284,308,000 1,550,624,000 1,680,004,000 1,755,861,000 823,724,000 822,976,000 835,003,000 876,959,000 927,409,000 326,072,000 14,585,000 16,447,000 18,309,000 20,171,000 22,033,000 23,895,000 25,757,000 27,802,000 29,858,000 31,915,000 33,972,000 35,794,000 32,526,000 65,663,000 71,074,000 74,919,000 36,040,000 58,664,000 60,952,000 
  goodwill1,843,974,000 1,760,045,000 1,716,323,000 1,804,646,000 1,735,931,000 1,739,495,000 1,753,130,000 1,705,320,000 1,742,675,000 1,723,444,000 1,692,662,000 1,592,635,000 1,687,648,000 1,782,444,000 1,827,609,000 1,849,547,000 1,887,699,000 938,398,000 958,303,000 937,099,000 918,021,000 909,226,000 906,725,000 924,990,000 919,972,000 932,422,000 936,493,000 960,509,000 941,428,000 926,290,000 899,290,000 927,993,000 661,845,000 670,991,000 669,029,000 664,015,000 654,470,000 724,388,000 760,314,000 763,763,000 446,823,000 439,014,000 436,355,000 437,652,000 446,236,000 239,737,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 38,213,000 
  deferred tax assets602,903,000 575,097,000 560,245,000 583,218,000 545,222,000 507,749,000 477,834,000 464,367,000 430,086,000 399,097,000 376,247,000 314,965,000 320,550,000 314,672,000 311,103,000 314,666,000 296,493,000 258,454,000 254,916,000 254,810,000 243,395,000 230,242,000 183,944,000 184,383,000 65,090,000 37,582,000 40,997,000 38,103,000       50,006,000 50,604,000 50,822,000 35,696,000 35,869,000 35,888,000 45,565,000 46,538,000 47,517,000                       
  deferred financing costs8,516,000 8,999,000 9,489,000 4,395,000 5,736,000 5,784,000 6,478,000 7,172,000 7,865,000 8,559,000 9,254,000 9,949,000 10,643,000 11,336,000 12,029,000 12,724,000 13,406,000 4,724,000 5,238,000 5,802,000 6,347,000 6,887,000 7,971,000 8,517,000 9,056,000 10,058,000 10,779,000 7,144,000 8,149,000 8,705,000 9,325,000 10,258,000 6,610,000 6,843,000 24,315,000 25,188,000 31,223,000 35,068,000 24,427,000 25,896,000 15,458,000 16,308,000 15,686,000                       
  other non-current assets121,271,000 116,516,000 114,482,000 75,231,000 71,425,000 70,780,000 67,464,000 76,080,000 65,978,000 64,076,000 55,139,000 35,153,000 34,612,000 35,508,000 40,813,000 45,776,000 47,082,000 30,351,000 25,721,000 38,646,000 48,828,000 47,107,000 44,274,000 40,835,000 40,736,000 56,003,000 23,404,000 22,985,000 16,420,000 16,638,000 17,625,000 37,764,000 37,005,000 29,543,000 25,393,000 22,498,000 19,189,000 13,482,000 11,135,000 9,296,000 6,391,000 5,502,000                        
  total assets10,944,141,000 11,534,682,000 12,012,257,000 12,255,716,000 11,361,868,000 11,327,075,000 11,393,359,000 11,204,065,000 11,260,540,000 11,047,125,000 10,835,255,000 10,384,667,000 11,200,133,000 11,768,917,000 12,298,639,000 12,478,152,000 13,212,993,000 6,756,470,000 6,535,901,000 6,291,958,000 6,066,501,000 5,215,295,000 5,527,850,000 5,488,661,000 5,280,235,000 5,485,788,000 5,348,967,000 5,287,128,000 4,999,024,000 4,804,024,000 4,815,824,000 4,930,581,000 3,448,094,000 3,534,979,000 3,464,300,000 3,393,274,000 3,237,593,000 3,347,536,000 3,155,749,000 3,196,434,000 2,185,499,000 2,093,880,000 2,009,690,000 1,726,699,000 1,697,944,000 895,360,000 253,573,000 207,813,000 193,409,000 154,178,000 135,729,000 107,992,000 97,264,000 106,706,000 107,396,000 102,172,000 108,574,000 109,937,000 117,498,000 179,793,000 186,591,000 239,018,000 207,554,000 258,767,000 276,870,000 
  liabilities and shareholders’ equity                                                                 
  current liabilities:                                                                 
  accounts payable89,366,000 95,930,000 77,869,000 85,425,000 97,096,000 80,976,000 102,750,000 109,850,000 98,428,000 125,454,000 90,758,000 102,249,000 74,161,000 73,336,000 100,298,000 63,815,000 64,826,000 77,738,000 26,945,000 67,063,000 50,043,000 66,308,000 70,104,000 82,222,000 42,669,000 37,373,000 31,379,000 46,933,000 29,972,000 28,529,000 29,144,000 17,626,000 28,406,000 32,622,000 29,124,000 26,409,000 27,317,000 29,671,000 32,555,000 72,538,000 22,434,000 20,367,000 31,634,000 20,535,000 34,505,000 13,689,000 5,129,000 8,463,000 4,665,000 3,648,000 3,049,000 3,891,000 6,403,000 3,885,000 2,158,000 5,240,000 4,074,000 4,554,000 5,736,000 6,614,000 8,522,000 8,915,000 2,856,000 2,872,000 4,268,000 
  accrued liabilities874,811,000 1,063,918,000 910,947,000 858,578,000 800,993,000 826,530,000 793,914,000 769,942,000 748,304,000 712,349,000 803,255,000 668,390,000 593,207,000 604,710,000 666,304,000 603,715,000 561,091,000 374,035,000 352,732,000 302,071,000 266,918,000 261,041,000 238,740,000 218,751,000 292,390,000 257,453,000 258,794,000 240,544,000 179,890,000 169,701,000 183,645,000 172,418,000 157,622,000 307,504,000 166,375,000 146,053,000 146,975,000 161,476,000 142,843,000 147,737,000 106,390,000 96,771,000 100,935,000 123,632,000 125,080,000 74,566,000 34,783,000 35,834,000 26,713,000 23,274,000 23,572,000 19,075,000 16,217,000 15,368,000 14,296,000 21,370,000 22,147,000 21,401,000 19,024,000 23,161,000 31,252,000 30,133,000 29,047,000 23,892,000 22,198,000 
  current portion of long-term debt1,028,478,000 31,000,000 31,000,000 31,000,000 605,798,000 605,375,000 604,954,000 604,507,000 31,000,000 31,000,000 31,000,000 31,000,000 31,000,000 31,000,000 31,000,000 31,000,000 248,585,000 248,613,000 246,322,000 243,999,000 33,387,000 33,387,000 33,387,000 33,387,000 33,387,000 33,387,000 33,387,000 45,117,000 36,094,000 36,094,000 136,094,000 36,094,000 37,500,000 37,592,000 117,589,000 28,478,000 9,388,000 9,444,000 9,473,000 9,513,000 5,572,000 5,572,000 32,656,000 26,719,000 23,750,000    32,693,000 16,131,000 16,064,000 15,995,000 15,925,000             
  income taxes payable78,550,000 31,762,000 18,757,000 54,974,000 52,138,000 49,325,000 35,074,000 89,026,000 67,529,000 40,095,000 7,717,000 10,444,000 5,796,000 26,677,000 9,608,000 34,256,000 3,645,000 49,334,000 25,200,000 25,910,000 55,979,000 31,211,000 43,488,000 30,413,000 40,833,000 7,139,000 17,934,000 36,048,000 13,603,000 7,494,000 35,300,000 5,222,000 1,761,000 19,735,000 16,357,000 13,456,000 26,334,000 15,755,000 5,500,000 824,000 19,850,000 17,539,000 37,803,000                       
  total current liabilities2,071,205,000 1,222,610,000 1,038,573,000 1,029,977,000 1,556,025,000 1,562,206,000 1,536,692,000 1,573,329,000 945,265,000 908,902,000 933,193,000 812,954,000 705,442,000 737,409,000 809,303,000 735,053,000 880,588,000 752,093,000 653,745,000 642,133,000 409,960,000 396,123,000 390,439,000 369,493,000 413,999,000 341,287,000 347,950,000 375,619,000 268,177,000 250,393,000 392,773,000 232,859,000 226,721,000 398,831,000 340,192,000 225,164,000 220,582,000 223,743,000 197,768,000 238,009,000 203,359,000 184,346,000 243,725,000 178,572,000 192,318,000 104,584,000 52,870,000 57,535,000 81,317,000 61,441,000 59,936,000 58,100,000 56,284,000 69,911,000 59,241,000 38,110,000 50,208,000 168,530,000 173,491,000 66,440,000 70,303,000 74,722,000 36,856,000 31,360,000 31,627,000 
  long-term debt, less current portion4,335,616,000 5,336,481,000 6,077,640,000 6,080,802,000 5,100,983,000 5,105,111,000 5,107,988,000 5,110,757,000 5,686,646,000 5,689,662,000 5,693,341,000 5,695,814,000 5,989,998,000 5,992,868,000 6,018,943,000 6,247,287,000 6,489,315,000 1,853,033,000 1,848,516,000 1,843,685,000 2,069,669,000 1,576,984,000 1,570,781,000 1,567,842,000 1,565,277,000 1,560,582,000 1,558,314,000 1,537,044,000 1,543,819,000 1,635,800,000 1,739,594,000 2,147,379,000 1,141,652,000 1,146,433,000 1,172,103,000 1,337,986,000 1,334,661,000 1,331,340,000 1,186,960,000 1,189,096,000 545,564,000 546,724,000 418,506,000 435,631,000 444,190,000     20,569,000 24,629,000 28,670,000 32,694,000             
  operating lease liabilities, less current portion55,107,000 38,780,000 38,938,000 71,115,000 67,617,000 56,158,000 59,225,000 61,892,000 65,547,000 72,095,000 71,838,000 72,984,000 77,845,000 83,078,000 87,200,000 89,359,000 156,556,000 136,020,000 140,035,000 141,925,000 144,264,000 147,110,000 153,434,000 156,289,000 154,066,000                                         
  deferred tax liabilities682,123,000 670,801,000 676,736,000 791,784,000 775,228,000 809,714,000 847,706,000 841,234,000 910,724,000 932,247,000 944,337,000 933,670,000 1,096,416,000 1,222,084,000 1,300,541,000 1,329,184,000 1,421,027,000 109,915,000 130,397,000 141,588,000 162,376,000 165,095,000 250,167,000 283,669,000 296,148,000 337,021,000 354,932,000 382,072,000                                      
  other non-current liabilities93,731,000 91,119,000 86,614,000 110,971,000 99,416,000 97,425,000 104,751,000 127,480,000 126,683,000 109,178,000 106,812,000 123,935,000 129,420,000 124,644,000 116,998,000 137,806,000 132,507,000 105,868,000 101,148,000 142,475,000 134,839,000 117,258,000 102,583,000 120,713,000 111,897,000 208,647,000 205,731,000 192,181,000 158,497,000 144,690,000 128,809,000 106,101,000 94,196,000 79,207,000 59,666,000 52,664,000 45,122,000 33,596,000 29,175,000 25,395,000 16,747,000 13,330,000 9,817,000 2,161,000 1,615,000 1,314,000                    
  commitments and contingencies                                                                 
  shareholders’ equity:                                                                 
  ordinary shares6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000  6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000                    
  non-voting euro deferred shares55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000  55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000 55,000                    
  capital redemption reserve473,000 473,000 473,000 473,000 473,000 473,000 473,000 473,000 473,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 472,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000 471,000                    
  additional paid-in capital4,000,280,000 3,925,161,000 3,913,542,000 3,837,698,000 3,779,114,000 3,714,283,000 3,699,954,000 3,639,940,000 3,580,115,000 3,511,732,000 3,477,124,000 3,387,997,000 3,312,319,000 3,239,327,000 3,534,792,000 3,469,884,000 3,403,482,000 2,694,858,000 2,633,670,000 2,537,989,000 2,499,135,000 2,294,474,000 2,209,156,000 2,171,458,000 2,130,738,000 2,078,032,000 2,037,091,000 1,955,756,000 1,899,628,000 1,720,584,000 1,681,774,000 1,635,431,000 1,617,069,000 1,586,750,000 1,534,032,000 1,512,450,000 1,488,262,000 1,431,790,000 1,273,159,000 1,251,587,000 1,201,221,000 1,184,965,000 1,168,633,000 1,133,542,000 1,126,371,000 1,103,498,000 542,697,000 528,682,000 521,429,000 513,108,000 505,413,000 498,516,000 496,263,000 437,179,000 434,811,000 430,852,000 422,724,000 421,497,000 407,923,000 405,689,000 379,437,000 375,607,000 371,440,000 368,136,000 366,165,000 
  accumulated other comprehensive loss-485,768,000 -785,610,000 -947,667,000 -603,397,000 -888,227,000 -882,394,000 -842,147,000 -1,035,399,000 -866,823,000 -980,230,000 -1,125,509,000 -1,617,646,000 -1,106,029,000 -590,720,000 -400,360,000 -397,517,000 -190,935,000 -179,428,000 -134,352,000 -187,801,000 -236,109,000 -257,436,000 -259,442,000 -210,436,000 -220,674,000 -179,466,000 -168,228,000 -98,768,000 -158,987,000 -210,249,000 -299,843,000 -235,376,000 -249,988,000 -222,284,000 -231,277,000 -248,042,000 -278,584,000        -388,000  -31,000 -2,000                  
  retained earnings191,313,000 1,034,806,000 1,127,347,000 936,232,000 871,178,000 864,038,000 878,656,000 884,298,000 811,849,000 803,006,000 733,586,000 974,310,000 993,958,000 959,347,000 830,226,000 865,577,000 918,410,000 1,281,726,000 1,159,894,000 1,026,480,000 878,246,000 770,929,000 1,104,158,000 1,021,879,000 819,850,000 1,128,218,000 1,000,356,000 929,050,000 728,123,000 690,164,000 601,522,000 315,415,000 324,844,000 242,441,000 260,176,000 181,828,000 95,066,000 -34,666,000 -53,946,000 -74,118,000                          
  total shareholders’ equity3,706,359,000 4,174,891,000 4,093,756,000 4,171,067,000 3,762,599,000 3,696,461,000 3,736,997,000 3,489,373,000 3,525,675,000 3,335,041,000 3,085,734,000 2,745,194,000 3,200,781,000 3,608,487,000 3,965,191,000 3,938,477,000 4,131,490,000 3,797,689,000 3,659,745,000 3,377,201,000 3,141,805,000 2,808,500,000 3,054,405,000 2,983,434,000 2,730,447,000 3,027,317,000 2,869,752,000 2,786,571,000 2,469,297,000 2,201,032,000 1,983,986,000 1,716,003,000 1,692,458,000 1,607,440,000 1,563,477,000 1,446,823,000 1,305,330,000 1,340,613,000 1,280,087,000  1,243,701,000 1,175,453,000 1,161,900,000 886,087,000 831,459,000 781,832,000                    
  total liabilities and shareholders’ equity10,944,141,000 11,534,682,000 12,012,257,000 12,255,716,000 11,361,868,000 11,327,075,000 11,393,359,000 11,204,065,000 11,260,540,000 11,047,125,000 10,835,255,000 10,384,667,000 11,200,133,000 11,768,917,000 12,298,639,000 12,478,152,000 13,212,993,000 6,756,470,000 6,535,901,000 6,291,958,000 6,066,501,000 5,215,295,000 5,527,850,000 5,488,661,000 5,280,235,000 5,485,788,000 5,348,967,000 5,287,128,000 4,999,024,000 4,804,024,000 4,815,824,000 4,930,581,000 3,448,094,000 3,534,979,000 3,464,300,000 3,393,274,000 3,237,593,000 3,347,536,000 3,155,749,000 3,196,434,000 2,185,499,000 2,093,880,000 2,009,690,000 1,726,699,000 1,697,944,000 895,360,000                    
  ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 60,631 and 62,255 shares issued and outstanding at december 31, 2024 and 2023, respectively  6,000                                                               
  non-voting euro deferred shares, €0.01 par value per share; 4,000 shares authorized, issued and outstanding at both december 31, 2024 and 2023  55,000                                                               
  deferred revenue       4,000 4,000 4,000 463,000 871,000 1,278,000 1,686,000 2,093,000 2,267,000 2,441,000 2,373,000 2,546,000 3,090,000 3,633,000 4,176,000 4,720,000 4,720,000 4,720,000 5,935,000 6,456,000 6,977,000 8,618,000 8,575,000 8,590,000 1,499,000 1,432,000 1,378,000 1,330,000 1,330,000 1,138,000 1,138,000 1,138,000 1,138,000 1,138,000 1,138,000 1,138,000 1,943,000 2,011,000 1,138,000 1,138,000 1,138,000 1,366,000 1,561,000 1,273,000 3,412,000 3,424,000 3,208,000 2,675,000 2,500,000 2,349,000 12,605,000 12,322,000 12,400,000 3,430,000 1,494,000 1,494,000 1,999,000 2,027,000 
  ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 62,255 and 63,214 shares issued and outstanding at december 31, 2023 and 2022, respectively      6,000                                                           
  non-voting euro deferred shares, €0.01 par value per share; 4,000 shares authorized, issued and outstanding at both december 31, 2023 and 2022      55,000                                                           
  deferred revenue, non-current           116,000 231,000 347,000 463,000 986,000 1,510,000 1,852,000 2,315,000 2,951,000 3,588,000 4,225,000 6,041,000 7,221,000 8,401,000 10,934,000 12,288,000 13,641,000 18,270,000 20,470,000 22,624,000 2,881,000 3,161,000 3,441,000 3,646,000 3,930,000 4,215,000 4,784,000 5,148,000 5,433,000 6,001,000 6,283,000 6,566,000 7,129,000 7,356,000 7,630,000 7,915,000 8,199,000 8,484,000 8,768,000 9,053,000 9,338,000 9,622,000 9,907,000 10,191,000         12,752,000 13,037,000 
  ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 63,214 and 61,633 shares issued and outstanding at december 31, 2022 and 2021, respectively          6,000                                                       
  non-voting euro deferred shares, €0.01 par value per share; 4,000 shares authorized, issued and outstanding at both december 31, 2022 and 2021          55,000                                                       
  assets held for sale             90,888,000             78,033,000                 59,546,000                      
  ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 61,633 and 56,171 shares issued and outstanding at december 31, 2021 and 2020, respectively              6,000                                                   
  non-voting euro deferred shares, €0.01 par value per share; 4,000 shares authorized, issued and outstanding at both december 31, 2021 and 2020              55,000                                                   
  ordinary shares, nominal value 0.0001 per share; 300,000 shares authorized; 56,171 and 56,140 shares issued and outstanding at december 31, 2020 and 2019, respectively                  6,000                                               
  non-voting euro deferred shares, €0.01 par value per share; 4,000 shares authorized, issued and outstanding at both december 31, 2020 and 2019                  55,000                                               
  property and equipment                            159,386,000 136,626,000 119,913,000 99,898,000 93,476,000 86,788,000 83,452,000 80,428,000 71,283,000 44,205,000 38,462,000 30,048,000 12,060,000 10,768,000 7,795,000 6,671,000 4,631,000 2,026,000 1,557,000 930,000 647,000 652,000 690,000 716,000 901,000 909,000 1,124,000 1,444,000 1,778,000 2,140,000 2,514,000 3,708,000 4,260,000 3,875,000 3,941,000 3,286,000 3,025,000 
  deferred tax assets, net, non-current                            23,662,000 20,158,000 18,038,000  117,507,000 122,036,000 76,391,000 73,280,000 74,185,000 101,249,000 96,495,000 94,250,000 70,976,000 65,136,000 62,933,000                       
  deferred tax liability, net, non-current                            540,964,000 551,639,000 548,038,000 725,358,000 289,906,000 299,627,000 325,216,000 326,707,000 327,683,000 413,460,000 456,611,000 471,993,000 170,127,000 167,744,000 169,176,000                       
  deferred tax liability                                  9,417,000 9,438,000 9,430,000 6,259,000 6,259,000 6,259,000 275,000 259,000 259,000 180,919,000 185,706,000                     
  jazz pharmaceuticals plc shareholders' equity                                                                 
  total jazz pharmaceuticals plc shareholders’ equity                                  1,563,463,000 1,446,768,000 1,305,276,000 1,340,523,000 1,279,691,000 1,248,893,000                          
  noncontrolling interests                                  14,000 55,000 54,000 90,000 396,000 17,615,000                          
  contingent consideration                                        47,700,000 42,700,000 39,300,000 36,200,000 35,300,000                     
  accumulated other comprehensive income                                     -57,133,000 59,946,000 70,892,000 44,622,000 19,220,000 10,606,000 13,860,000  3,000             4,000 -3,000  12,000 19,000 1,000  
  total shareholders' equity                                       1,266,508,000                          
  contingent consideration, non-current                                                                 
  accumulated deficit                                        -2,674,000 -29,264,000 -17,871,000 -261,847,000 -295,056,000 -322,201,000 -349,882,000 -387,355,000 -419,837,000 -453,039,000 -474,866,000 -499,325,000 -512,568,000 -506,180,000 -507,644,000 -513,297,000 -511,625,000 -513,796,000 -500,808,000 -443,868,000 -415,058,000 -363,179,000 -316,469,000 -256,449,000 -237,090,000 
  other long-term assets                                          4,546,000 20,405,000 19,226,000 385,000 87,000 83,000 152,000 302,000 335,000 371,000 310,000 1,040,000 1,247,000 1,456,000 1,886,000 246,000 246,000 2,505,000 2,848,000 2,766,000 1,269,000 1,541,000 1,440,000 
  marketable securities                                             73,564,000 75,822,000 12,133,000           1,004,000 999,000 1,500,000 4,410,000  10,939,000  
  purchased product rights liability                                           5,743,000 6,972,000 15,191,000 4,500,000 4,875,000 4,750,000 4,625,000 4,500,000 4,375,000 4,250,000 4,125,000 4,000,000 6,000,000 7,000,000 6,000,000 14,000,000 21,000,000 21,000,000 31,000,000    
  liability under government settlement                                              7,320,000 7,225,000 7,130,000 8,202,000 4,128,000 4,002,000 2,715,000 2,594,000 2,954,000   10,658,000 13,063,000 13,063,000 13,063,000 13,063,000 14,881,000   
  restricted cash                                                 400,000 400,000 400,000 910,000 951,000 2,988,000 950,000 1,075,000 775,000 1,913,000 1,998,000 1,998,000 1,998,000 1,939,000 304,000 275,000 
  liabilities and stockholders’ equity                                                                 
  revolving credit facility                                                4,000,000 4,000,000 7,350,000 7,350,000 7,350,000             
  purchased product rights liability, non-current                                               750,000 2,000,000 3,250,000 4,500,000 5,625,000 6,750,000 7,875,000 9,000,000           
  liability under government settlement, non-current                                                  6,978,000 6,978,000 8,142,000 8,142,000 10,658,000         14,881,000 14,881,000 
  deferred rent                                                12,000 77,000 82,000 86,000 73,000 51,000 29,000 7,000          
  stockholders’ equity:                                                                 
  preferred stock, 0.0001 par value; 20,000 shares authorized; none outstanding                                                                 
  common stock                                              4,000 4,000 4,000 4,000 4,000 4,000 4,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 2,000 2,000 2,000 2,000 2,000 
  total stockholders’ equity                                              192,788,000 141,329,000 101,596,000 60,073,000 30,551,000        -92,878,000 -38,179,000 -35,619,000 12,442,000 54,992,000 111,690,000 129,077,000 
  total liabilities and stockholders’ equity                                              253,573,000 207,813,000 193,409,000 154,178,000 135,729,000        117,498,000 179,793,000 186,591,000 239,018,000    
  stockholders’ equity                                                                 
  preferred stock, 0.0001 par value; 20,000,000 shares authorized at december 31, 2010; no shares issued and outstanding at december 31, 2010                                                                 
  liabilities and stockholders’ deficit                                                                 
  stockholders’ deficit:                                                                 
  total stockholders’ deficit                                                   -805,000 -16,301,000 -68,998,000 -72,830,000 -82,442,000 -88,898,000 -92,296,000        
  total liabilities and stockholders’ deficit                                                   107,992,000 97,264,000 106,706,000 107,396,000 102,172,000 108,574,000 109,937,000        
  revenues:                                                                 
  product sales                                                   43,838,000 39,528,000 34,283,000 115,108,000 29,992,000 26,478,000 21,319,000        
  royalties                                                   630,000 674,000 605,000 2,203,000 532,000 518,000 472,000        
  contract revenues                                                   285,000 284,000 285,000 11,138,000 285,000 10,284,000 285,000        
  total revenues                                                   44,753,000 40,486,000 35,173,000 128,449,000 30,809,000 37,280,000 22,076,000        
  operating expenses:                                                                 
  cost of product sales                                                   3,091,000 2,802,000 2,882,000 9,638,000 2,338,000 2,575,000 1,943,000        
  research and development                                                   7,317,000 7,962,000 6,215,000 36,561,000 7,644,000 11,192,000 11,408,000        
  selling, general and administrative                                                   18,040,000 17,096,000 16,790,000 58,652,000 15,061,000 13,657,000 14,216,000        
  intangible asset amortization                                                   1,862,000 2,044,000 2,057,000 7,668,000           
  total operating expenses                                                   30,310,000 29,904,000 27,944,000 112,519,000 27,100,000 29,246,000 29,299,000        
  income from operations                                                   14,443,000 10,582,000 7,229,000 15,930,000 3,709,000 8,034,000 -7,223,000        
  interest income                                                   1,000 2,000 2,000 34,000 2,000 6,000 21,000        
  interest expense                                                   -1,197,000 -4,687,000 -5,767,000 -22,796,000 -5,384,000 -5,856,000 -5,794,000        
  other income                                                   -4,000 2,000  -4,000 1,000 -13,000 8,000        
  loss on extinguishment of debt                                                    -12,287,000             
  net income                                                   13,243,000 -6,388,000 1,464,000 -6,836,000 -1,672,000 2,171,000 -12,988,000        
  net income per share                                                      -230   -450        
  basic                                                   340 -180 50   70         
  diluted                                                   320 -180 40   70         
  weighted-average common shares used in computing net income per share:                                                                 
  line of credit                                                     7,840,000 9,399,000 3,000,000   3,875,000 3,265,000 6,099,000 3,180,000 3,459,000 2,597,000 3,134,000 
  senior secured notes                                                     32,891,000 23,759,000  14,638,000 123,970,000 118,534,000 113,614,000 113,704,000 113,367,000 75,116,000 74,862,000 74,622,000 
  common stock subject to repurchase                                                          12,492,000 13,241,000 13,241,000 13,241,000 13,241,000 13,222,000 13,174,000 
  preferred stock, 0.0001 par value; 20,000,000 shares authorized at december 31, 2009 and 2008; no shares issued and outstanding at december 31, 2009 and 2008, respectively                                                                 
  intangible asset impairment                                                                 
  benefit from government settlement                                                                 
  gain on sale of product rights                                                                 
  weighted-average common shares used in computing net income per share, basic and diluted                                                      30,018,000   28,925,000        
  purchased product rights liability, noncurrent                                                       10,000,000 11,000,000 12,000,000        
  deferred revenue, noncurrent                                                       10,476,000 10,761,000 11,045,000        
  liability under government settlement, noncurrent                                                       10,658,000 10,658,000         
  amortization of intangible assets                                                       2,057,000 1,822,000 1,732,000        
  basic and diluted                                                       -50          
  long-term restricted cash and investments                                                              12,000,000 12,085,000 12,085,000 
  non-current portion of deferred revenue                                                          11,330,000 11,614,000 11,899,000 12,183,000 12,468,000   
  preferred stock, 0.0001 par value; 20,000,000 shares authorized at december 31, 2008 and 2007; no shares issued and outstanding at december 31, 2008 and 2007, respectively                                                                 
  liabilities, convertible preferred stock, and stockholders’ equity                                                                 
  preferred stock warrant liability                                                                 
  liability for early exercise of options and unvested restricted common stock                                                                 
  convertible preferred stock                                                                 
  preferred stock, 0.0001 par value; 20,000,000 and no shares authorized at december 31, 2007 and 2006, respectively; no shares issued and outstanding at december 31, 2007 and 2006, respectively                                                                 
  total liabilities, convertible preferred stock and stockholders’ equity                                                              207,554,000 258,767,000 276,870,000 
  liabilities, convertible preferred stock and stockholders’ equity                                                                 
  deferred rent and other non-current liabilities                                                                452,000 

We provide you with 20 years of balance sheets for Jazz Pharmaceuticals plc stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Jazz Pharmaceuticals plc. Explore the full financial landscape of Jazz Pharmaceuticals plc stock with our expertly curated balance sheets.

The information provided in this report about Jazz Pharmaceuticals plc stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.